Improving Human Cerebrovascular Function Using Acute Intermittent Hypoxia

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

33 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-05-03

Study Completion Date

2024-04-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study uses magnetic resonance imaging to determine whether 3 weeks of repeated exposure to Acute Intermittent Hypoxia can improve brain blood flow or blood flow regulation in healthy adults.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Study of Brain Blood Flow During Induced Hypercapnia (Excess Blood Carbon Dioxide)

NCT00001845

Healthy Hypercapnia

COMPLETED

High-field Brain Magnetic Resonance Spectroscopy

NCT02053701

Healthy

ACTIVE_NOT_RECRUITING

Magnetic Resonance Venography Pre- and Post-Treatment in Patients With Idiopathic Intracranial Hypertension

NCT02394067

Pseudotumor Cerebri

COMPLETED

MR Perfusion Imaging and Hypercapnia (Increased Carbon Dioxide) to Study New Blood Vessel Formation in Multiple Sclerosis

NCT00064909

Multiple Sclerosis

COMPLETED

Hyperbaric Oxygen Treatment in Patients With White Matter Hyperintensities

NCT00497432

Neurological Impairments Leukoencephalopathies

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study aims to identify an intervention to improve the function of blood vessels in the human brain, in order to mitigate damage to overall brain function and improve health outcomes across the lifespan. Hypoxia is a potent driver of angiogenesis and vascular plasticity, and acute intermittent hypoxia (AIH) protocols, in which an individual alternates between breathing mildly hypoxic air and normal air, are being rigorously examined for their potential in improving human physiology. This study tests whether AIH evokes beneficial vascular plasticity in the human brain, using a randomized crossover design to determine the impact of different daily AIH or sham interventions on MRI measures of cerebrovascular physiology.

Healthy, able-bodied participants between 21 and 50 years old will be invited to participate in this study. The daily AIH intervention consists of repeated visits to the PI laboratory over a three-week period to have an AIH or sham protocol administered via a hypoxia generator and face mask (Hyp-123, Hypoxico). Blood pressure readings will be taken before and after all intervention visits, and SpO2 levels continuously recorded for safety monitoring.

The effectiveness of the different interventions at improving cerebrovascular function will be assessed using MRI. In the week prior to each intervention period the participant will undergo MRI scanning. In addition to structural and diffusion weighted scans, multiple perfusion metrics will be extracted. Whole-brain cerebral blood flow will be measured using phase-contrast MRI, and quantitative CBF maps of regional perfusion will be measured using arterial spin labeling MRI. These perfusion metrics will be acquired three times: during normoxic (baseline), hypoxic, and hypercapnic conditions. Changes in perfusion values during gas challenges will measure whole-brain and regional cerebrovascular reactivity. The MRI protocol will be repeated one day after the last intervention visit.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Brain Perfusion

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Randomized sham-controlled crossover trial

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

SINGLE

Participants

Participants will not know whether they are receiving active or sham hypoxia during individual AIH sessions.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intermittent Hypoxia

Participant will visit our center 2-4 times per week for three weeks to receive Acute Intermittent Hypoxia.

Group Type ACTIVE_COMPARATOR

Acute Intermittent Hypoxia

Intervention Type OTHER

Participants will wear a non-rebreathing face mask and alternate between breathing 9% O2 gas mixture for up to 1 minute, or until the target SpO2 of 85 percent is reached, and normal room air (21 percent O2) until 2 minutes are complete. This cycle will be repeated 15 times, resulting in a 30-minute protocol.

Sham Intermittent Hypoxia

Participants will visit our center 2-4 times per week for three weeks to receive Sham Intermittent Hypoxia.

Group Type SHAM_COMPARATOR

Sham Acute Intermittent Hypoxia

Intervention Type OTHER

Participants will wear a non-rebreathing face mask and breathe normal air (21 percent O2) for 30-minutes.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Acute Intermittent Hypoxia

Participants will wear a non-rebreathing face mask and alternate between breathing 9% O2 gas mixture for up to 1 minute, or until the target SpO2 of 85 percent is reached, and normal room air (21 percent O2) until 2 minutes are complete. This cycle will be repeated 15 times, resulting in a 30-minute protocol.

Intervention Type OTHER

Sham Acute Intermittent Hypoxia

Participants will wear a non-rebreathing face mask and breathe normal air (21 percent O2) for 30-minutes.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy volunteers between ages of 21 and 50 years
* No known neurological, respiratory or vascular conditions
* Safe to be scanned using MRI
* Able to communicate in English

Exclusion Criteria

* MRI contraindications as indicated on MRI safety screening form
* Subjects with pacemakers, cochlear (in the ear) implants, or aneurysm clips or subjects who have worked with metal
* Pregnant women
* Individuals with known neurological or vascular conditions
* Individuals with sleep apnea, emphysema, or other respiratory conditions
* Individuals with severe claustrophobia
* Subjects unwilling or unable to give written informed consent in English
* Prisoners
* Frequent smoker
* Allergy to Tegaderm
* Blood pressure greater than 140/90 or less than 90/55.
* Individuals who report headaches, feeling dizzy or light-headed, or have heart palpitations on the day of the study.
* Individuals prescribed Aripiprazole and/or Lamotrigine\*

Note, mild (well-controlled) asthma is not immediate grounds for exclusion.

\*Other prescription medications may be grounds for exclusion; prescription medication information will be acquired during initial screening and at subsequent follow-up visits

Minimum Eligible Age

21 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes